A Study of LY2835219 in Japanese Participants With Advanced Cancer

Clinical trial NCT02014129 · COMPLETED

Trial details

NCT number: NCT02014129
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Metastasis Lymphoma

Start date: 2013-12-18
Primary completion: 2015-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.